Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 223

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

Open access
Mont, Lluís, Pelliccia, Antonio, Sharma, Sanjay, Biffi, Alessandro, Borjesson, Mats, Terradellas, Josep Brugada, Carré, François, Guasch, Eduard, Heidbuchel, Hein, Gerche, André La, Lampert, Rachel, McKenna, William, Papadakis, Michail, Priori, Silvia G., Scanavacca, Mauricio, Thompson, Paul, Sticherling, Christian, Viskin, Sami, Wilson, Mathew, Corrado, Domenico, Reviewers:, Lip, Gregory Y.H., Gorenek, Bulent, Lundqvist, Carina Blomström, Merkely, Bela, Hindricks, Gerhard, Hernández-Madrid, Antonio, Lane, Deirdre, Boriani, Guiseppe, Narasimhan, Calambur, Marquez, Manlio F., Haines, David, Mackall, Judith, Marques-Vidal, Pedro Manuel, Corra, Ugo, Halle, Martin, Tiberi, Monica, Niebauer, Josef, Piepoli, Massimo · 2016 · Europace

Abstract

Introduction 140 Incidence of sudden cardiac death in athletes 140 Causes of sudden cardiac death in athletes 141 Hypertrophic cardiomyopathy 141 Arrhythmogenic right ventricular cardiomyopathy 144 Coronary congenital abnormalities 144 Ventricular pre-excitation 145 Left ventricle non-compaction 146 Dilated cardiomyopathy 147 Valvulopathies 147 Inherited primary arrhythmia syndromes 148 Long QT syndrome 148 Short QT syndrome 148 Catecholaminergic polymorphic ventricular tachycardia 149 Brugada syndrome 150 Acquired cardiac abnormalities 150 Coronary artery disease 150 Chagas disease 151 Myocarditis 152 Exercise as a promoter of cardiac injury 152 Role of screening techniques 152 Role of electrocardiogram 152 Role of ECG exercise test 154 Role of ambulatory ECG monitoring 154 Role of imaging modalities in screening 155 Echocardiography 155 Cardiac magnetic resonance imaging 155 Computed Tomography […] coronary angiography and coronary artery calcium scoring 155 Existing screening programmes, rationale, and limitations 156 Evidence supporting preparticipation evaluation programmes: impact on cardiovascular mortality 156 Cost-effectiveness considerations 157 Consensus statements 158 Aim and nature of the preparticipation evaluation 159 Protocol of the preparticipation evaluation 159 Implementation of the preparticipation evaluation 159 Future directions 159 References 159 acute myocardial infarction arrhythmogenic right ventricular cardiomyopathy Brugada syndrome coronary artery calcium score coronary artery disease Chagas heart disease cardiac magnetic resonance catecholaminergic polymorphic ventricular tachycardia computed tomography coronary angiography cardiovascular dilated cardiomyopathy European Association for Cardiovascular Prevention and Rehabilitation hypertrophic cardiomyopathy late gadolinium enhancement long QT syndrome left/right ventricle left ventricle hypertrophy non-sustained ventricular tachycardia preparticipation evaluation premature ventricular contractions sudden cardiac arrest/death transthoracic echocardiography ventricular fibrillation ventricular tachycardia Sudden cardiac death (SCD) associated with athletic activity is a rare but devastating event. Victims are usually young and apparently healthy, and while many of these deaths remain unexplained, a substantial number of victims harbour an underlying and potentially detectable cardiovascular (CV) disease.1–4 The vast majority of these events are due to malignant tachyarrhythmias, usually ventricular fibrillation (VF) or ventricular tachycardia (VT) degenerating into ventricular fibrillation (VF), occurring in individuals with arrhythmogenic disorders (e.g. hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, channelopathies). Intensive exercise training and competitive sport participation is a trigger that may favour insurgence of ominous ventricular tachyarrhythmias in predisposed individuals.5 Consequently, there is a great interest in early identification of at-risk individuals for whom appropriate treatment, followed or not by physical activity adjustment, may be implemented to minimize the risk of SCD. However, the role of pre-participation evaluation (PPE) in athletes as a feasible and efficient strategy to identify individuals at risk has remained controversial. There are several points that have been debated in the recent years, including the actual incidence of acute cardiac events in the athlete's population, the diagnostic capability, as well as the specificity and sensitivity of the testing commonly in use to identify the cardiac conditions at-risk (particularly, but not only,6 12-lead ECG), the impact of the screening protocols on the clinical outcome, and finally the cost/efficacy considerations. The target of this document is ‘athletic participants’, here defined as individuals of any age, either amateur or professional, who are engaged in regular exercise training, independent of the competitive status. We acknowledge that not uncommonly athletic participants, regardless of the level of achievement, have the inclination to exert physically up to their limits to improve performance. The purpose of the present position paper promoted by EHRA and EACPR and endorsed by APHRS, HRS, and SOLAECE, is to review the scientific evidence regarding the appropriate diagnostic methods to identify the cardiac conditions at risk in the athletic population, discuss the role of the different tests in the context of PPE and, finally, offer the consensus opinions relative to the most efficient pre-participation screening to improve safe sport participation, according to the current scientific evidence and—if necessary—to update the last recommendations on this topic.7,8 Notably, consequences of PPE such as the most appropriate medical treatment for a certain condition or criteria to be used for disqualification from intensive exercise are discussed elsewhere.7,9–12 Our interest for safe sport participation is dictated by the awa

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/europace/euw243

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 223

Metadata

Authors
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Terradellas, J. B., Carré, F., Guasch, E., Heidbuchel, H., Gerche, A. L., Lampert, R., McKenna, W., Papadakis, M., Priori, S. G., Scanavacca, M., Thompson, P., Sticherling, C., Viskin, S., Wilson, M., Corrado, D., Reviewers:, Lip, G. Y. H., Gorenek, B., Lundqvist, C. B., Merkely, B., Hindricks, G., Hernández-Madrid, A., Lane, D., Boriani, G., Narasimhan, C., Marquez, M. F., Haines, D., Mackall, J., Marques-Vidal, P. M., Corra, U., Halle, M., Tiberi, M., Niebauer, J., & Piepoli, M.
Venue
Europace
Published
2016-11-04
Volume
19
Issue
1
Pages
euw243
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2547524935
Cited by
223
References
20
FWCI
20.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. https://app.cochat.ai/papers/10.1093/europace/euw243
The paper
Mont, L., Pelliccia, A., Sharma, S., Biffi, A., Borjesson, M., Terradellas, J. B., Carré, F., Guasch, E., Heidbuchel, H., Gerche, A. L., Lampert, R., McKenna, W., Papadakis, M., Priori, S. G., Scanavacca, M., Thompson, P., Sticherling, C., Viskin, S., Wilson, M., . . . Piepoli, M. (2016). Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Europace. https://doi.org/10.1093/europace/euw243

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.